CEO of the Lundbeck Foundation defends share split proposal

It provoked criticism when the majority stakeholder in pharmaceutical firm Lundbeck, the Lundbeck Foundation, proposed a new share structure entailing shares with weaker voting rights than others. Opponents said this would dilute shares without the majority owner having to relinquish any power.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck faces criticism over new share structure
For subscribers